Cancer Stem Cells: Constantly Evolving and Functionally Heterogeneous Therapeutic Targets.

Tao Yang,Kiera Rycaj,Zhong-Min Liu,Dean G Tang
DOI: https://doi.org/10.1158/0008-5472.can-14-0266
IF: 11.2
2014-01-01
Cancer Research
Abstract:Elucidating the origin of and dynamic interrelationship between intratumoral cell subpopulations has clear clinical significance in helping to understand the cellular basis of treatment response, therapeutic resistance, and tumor relapse. Cancer stem cells (CSC), together with clonal evolution driven by genetic alterations, generate cancer cell heterogeneity commonly observed in clinical samples. The 2013 Shanghai International Symposium on Cancer Stem Cells brought together leaders in the field to highlight the most recent progress in phenotyping, characterizing, and targeting CSCs and in elucidating the relationship between the cell-of-origin of cancer and CSCs. Discussions from the symposium emphasize the urgent need in developing novel therapeutics to target the constantly evolving CSCs.
What problem does this paper attempt to address?